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Abstract.  During budding in Saccharomyces 
cerevisiae,  maternal  vacuole material is delivered into 
the growing daughter cell via tubular or vesicular 
structures.  One of the late steps in vacuole inheritance 
is the fusion in the bud of vesicles derived from the 
maternal vacuole. This process has been reconstituted 
in vitro and requires isolated vacuoles, a physiological 
temperature,  cytosolic factors, and ATP (Conradt,  B., 
J.  Shaw,  T.  Vida,  S. Emr,  and W. Wickner.  1992. J. 
Cell Biol.  119:1469-1479).  We now report a  simple 
and reliable assay to quantify vacuole-to-vacuole fu- 
sion in vitro.  This assay is based on the maturation 
and activation of vacuole membrane-bound pro-alkaline 
phosphatase by vacuolar proteinase A  after vacuole-to- 
vacuole fusion.  In vitro fusion allowed maturation of 
30 to 60%  of pro-alkaline phosphatase.  Vacuoles pre- 
pared from a mutant defective in vacuole inheritance 
in vivo (vac2-1) were inactive in this assay.  Vacuole 
fusion in vitro required a vacuole membrane potential. 
Inhibition by nonhydrolyzable guanosine derivatives, 
mastoparans,  and benzalkonium chloride suggest that 
GTP-hydrolyzing G proteins may play a key role in 
the in vitro fusion events. 
D 
VZDING cells use specific mechanisms to ensure cor- 
rect  inheritance  of cytoplasmic  organelles.  High 
copy number organelles may be partitioned predom- 
inantly  by random diffusion  (Birky,  1983).  Single  or low 
copy number mammalian  organelles  such as the Golgi ap- 
paratus vesiculate,  partition  during mitosis, and reassemble 
by fusion after cytokinesis (Lucocq and Warren,  1987; Ho 
et al., 1989). Mammalian lysosomes are usually clustered in 
the perinuclear region. During cell division, these organelles 
disperse,  and they recluster at the end of mitosis (Matteoni 
and Kreis,  1987). 
Vacuoles,  the  functional  equivalents  in  Saccharomyces 
cerevisiae of mammalian lysosomes, are low copy number 
organelles  occupying •10-20%  of the overall  cell volume 
(Gomes de Mesquita et al.,  1991; Raymond et al.,  1992). 
Cytological and genetic studies have elucidated some of the 
basic principles  of vacuole inheritance  mechanisms  in  S. 
cerevisiae (Weisman et al., 1987, 1990; Weisman and Wick- 
ner, 1988; Gomes de Mesquita et al., 1991; Shaw and Wick- 
ner,  1991; Raymond et al.,  1992; Weisman  and  Wickner, 
1992).  The  mother  cell  vacuole does  not  fragment,  but 
projects tubular  and/or  vesicular  structures  into  the bud 
early in S phase.  This transport ceases by the time of G2/M 
transition.  The vesicular structures fuse in the new daughter 
cell  to  form  one  or  a  few larger  vacuoles.  Vacuole  in- 
heritance is blocked in the mutant vac2-1, while traffic from 
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the Go!gi apparatus  to the vacuole is unimpaired  (Shaw and 
Wickner, 1991). Vesiculation and fusion of vacuoles can also 
be observed in a cell-free vacuole inheritance  reaction (Con- 
radt et al., 1992), allowing biochemical analysis of  the struc- 
tural and regulatory components of the vacuole segregation 
machinery. 
Similar in vitro assays have been developed for reconstitut- 
ing  transport  and  fusion processes,  such  as  ER-to-Golgi 
transport (Beckers et al., 1987; Baker et al., 1988), transport 
through the Golgi stack (Balch et al.,  1984), nuclear enve- 
lope assembly (Boman et al.,  1992), and endosome fusion 
(Mayorga  et al.,  1989a).  Most of these assays  are either 
based on: (a) the mixing of luminal contents of such vesicles 
(measured by glycosylation of reporter proteins);  (b) the for- 
marion of immune complexes  (quantified  after coprecipita- 
tion); or (c) the increase in size of fused vesicles (measured 
microscopically; for a review on these methods see Pryer et 
al.,  1992).  These  in  vitro  assays  have  shown  that  GTP- 
hydrolyzing proteins (G-proteins~; Bourne et al., 1991) play 
an important role in intracellular  transport.  Guanosine 5'-0- 
(3-thiotriphosphate)  (GTP),S),  a non-hydrolyzable  analogue 
of GTP,  prevents  G-protein cycling  and inhibits  transport 
1. Abbreviations  used in this paper: BAC, banzalkonium chloride;  CCCP, 
carbonyl  cyanide  m-chlorophenyl-hydrazone;  CDCFDA,  5  (and  6-)car- 
boxy-2',7'-dichlorofluccescein  diaeetate; cGMP, guanosine 3':5'-cyclic mono- 
phosphate; CPY, carboxypeptidase Y; G-protein, GTP-hydrolyzing protein; 
GDP, guanosine  5'-diphosphate;  GDP/3S, guanosine  5'-o-(2-thiodiphos- 
phate); GTP/~S (Rp-isomer), guanosine 5'-o-(3-thiotriphosphate); mas, mas- 
toparan; pNPP, para-nitrophenyl  phosphate;  vps,  vacuole protein sorting. 
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The Journal of Cell Biology, Volume 126, Number 1, July 1994 87-97  87 from the ER to the Golgi apparatus (Baker et al., 1988; Ruo- 
hola et al.,  1988; Beckers et al.,  1989; Rexach and Schek- 
man,  1991;  Gruenberg and  Clague,  1992;  Pfeffer,  1992), 
transport within the Golgi stack  (Melancon et al.,  1987), 
retrograde transport from the Golgi apparatus to the ER (Tan 
et  al.,  1992),  secretory  vesicle  formation  (Leyte  et  al., 
1992), endocytosis (Carter et al.,  1993), and endosome fu- 
sion (Colombo et al.,  1992).  In yeast,  distinct monomeric 
G-proteins participate  in  each  step  of vesicular transport 
(Sec4p,  Sarlp, Yptlp, Arflp, Arf2p;  for a  review see Pryer 
et al.,  1992). 
Heterotrimeric  ("large")  G-proteins are  also  involved in 
vesicular transport in a number of mammalian systems (Stow 
et al., 1991; Bomsel and Mostov,  1992; Leyte et al.,  1992). 
Mastoparan, a wasp venom 14-mer peptide, was a very use- 
ful tool in these studies. This peptide stimulates the exchange 
of GTP for guanosine 5'-diphosphate (GDP) on some or-sub- 
units of heterotrimeric G-proteins by binding to their COOH 
termini and mimicking an agonist-activated receptor (Higa- 
shijima et al., 1988,  1990; Mousli et al.,  1990; Weingarten 
et al.,  1990; Tomita et al.,  1991; Oppi et al.,  1992).  Thus, 
binding ofmastoparan constitutively stimulates these hetero- 
trimeric G-proteins, inhibiting in vitro ER-to-Golgi trans- 
port (Schwaninger et al.,  1992), endocytosis (Carter et al., 
1993), endosome fusion (Colombo et al., 1992), exocytosis 
in chromaltin cells (Vitale et al., 1993), and apical transport 
in epithelial cells (Pimplikar and Simons, 1993; for a recent 
review  see Bomsel and Mostov,  1992).  Mastoparans have 
not yet been used to study trafficking processes  in yeast. 
Rapid, quantitative assays are needed for the purification 
of proteins involved in vacuole inheritance and to define re- 
agents which interfere with the underlying processes  (e.g., 
G-protein inhibitors). We now report such an in vitro assay 
for  at least  some  of the  late  steps  in vacuole inheritance, 
vacuole-to-vacuole fusion. This assay has been used to iden- 
tify reagents which interfere with inter-vacuole fusion and to 
stage the fusion reaction (see accompanying paper; Conradt 
et al.,  1994). 
Materials and Methods 
Yeast Strains and Media 
S.  cerevisiae  K91-1A (unpublished  data)  MAT  a  pho8::pAL134 
pho13::pPH13 ura3 lysl was a generous gift of Dr. Y. Kaneko (Institute for 
Fermentation,  Osaka,  Japan).  Further  S.  cerevisiae  strains  used  were: 
BJ3505 (MA~ pep4::HIS3 prbl-Al.6R HIS3 1ys2-208 trpl-AlO1 ura3-52 ~-: 
gal2 card; Jones et al., 1982), DKY6281 (MATa leu2-3 leu2-112 ura3-52 
his3-A200 trpl-A901  lys2-801 suc2-A9  pho8::TRPl;  kindly supplied bY Dr. 
D. Klionsky, University of California, Davis, CA), ABYS1 (MATctpralprbl 
prcl cpsl ade; Achstetter et al., 1984), GPY449 (MATt~  1eu2-3,112 ura 3-52 
his4 trpl canl  R PEP4:  :LE02), JSYI14 (VAC1  + vac2-1 ade2-201 ura3-52 his 
4-519  leu2-112  leu2-3 PEP4::URA3),  JSYll5  (VACI  + vac2-1 ade2-201 
ura3-52 his 4-519 leu2-112 leu2-3 PHO8::LEU2),  JSY116 (MATa 1eu2-3,112 
ura3-52 his4 trpl canlR PHOS::LEU2)  (JSYll4,  115, and 116 were from 
Dr. J. Shaw, University of Utah, Salt Lake City, UT). YEPD (20 g bacto- 
peptone,  10 g yeast extract [Difco Laboratories, Inc., Detroit, MI], 20 g 
dextrose; each per liter) was used as a rich growth medium in all experiments. 
Materials 
TriX-pan 400 and TMAXp3200 films were used for microscopic photogra- 
phy. Samples were loaded in 6 mm wells of immunofluorescence slides 
(teflon-coated; Polyscience, Niles, IL) and stained with 5 (and 6-) carboxy- 
2',7'-dichlorofluorescein  diacetate (CDCFDA) from Molecular Probes Inc. 
(Eugene,  OR). Oxalyticase  was  from  Enzogenetics  (Corvallis,  OR), 
DEAE dextran, Ficoll 400, ATE and GTP from Pharmacia LKB Biotech- 
nology Inc. (Piscataway, NJ), creatine phosphokinase, creatine phosphate, 
and  guanosine  5'-o-(2-thiotriphosphate),  (Rp-isomer) (GTP/3S [Rp-iso- 
met]) were from Boehringer Mannheim Corp. (Indianapolis, IN), and the 
ECL-chemiluminescence development kit from Amersham Corp. (Arling- 
ton Heights, IL). Protein concentrations were determined using the Bio-Rad 
protein assay reagent kit (Richmond, CA) using bovine serum albumin as 
a standard. Sigma Chemical Co. (St. Louis, MO) provided GTP3,S, guano- 
sine  5'-o-(z-thiophosphate)  (GDP/3S), benzalkonium  chloride  (Cl~-m4), 
neomycin  sulfate,  p-nitrophenyl  phosphate  (pNPP)/TRIS  salt,  Triton 
X-100, DTT, carbonyl cyanide m-chlorophenyl-hydrazone (CCCP),  and 
PMSE Bafilomycin AI was kindly provided by Dr. K. Altendorf (Univer- 
sita't Osnabriick, Osnabriick, Germany). The anti-PHO8 serum used in 
Western blot analysis was kindly provided by Dr. T. Stevens (University of 
Oregon, Eugene, OR). 
Mastoparans 
Highly pure mastoparans (mas) (>95 %) were purchased either from Penin- 
sula Laboratories  Inc. (Belmont, CA; mas, INLKALAALAKKIL-NH:; 
mas  X,  INWKGIAAMAKKLL-NH2;  masl7,  INLKALAALAKALL- 
NH2), or were custom synthesized and prepurified (>90%) by BioSynthe- 
sis Inc. (Lewisville, TX; mas-PEF2, LKIALNLKALIAAK-NH2), or were 
generous gifts from Dr. Tsutomu Higashijima (University of Texas, Dallas, 
TX; masT[Glu4;Glnll], INLQALALAALAQALL-NH2;  purity >98%) or 
from Dr. Cristina Oppi (Istituto Guido Donegani, Rome, Italy; mas-PEP7, 
LNAKLKAIALALIK-NH2; mas-PEP8, NILALAKALIKALK-NH2). 
Preparation of  Soluble Yeast  Fraction (Cytosol) 
Cytosol was prepared on a small scale according to Conradt et al. (1992). 
Large scale preparations were done from fermenter material, using K91-1A 
cells (1 kg wet weight) grown overnight to an OD600 of 4.0-5.0 in YPD (25 
mg/1 kanamycin sulfate) at 30°C. The cells were suspended in 2 liters of 
ice cold water, centrifuged for 5 rain at 5,000 g, resuspended in 150 ml of 
lysis buffer (0.3 M sorbitol,  150 raM KAc, 20 mM Pipes/KOH, pH 6.8, 5 
mM MgC12, 1 mM DTT, 0.5 mM PMSF), and disrupted batchwise in a 
"beat beater" (Biospec Products, Bartlesville, OK; 50% (vol/vol) resus- 
pended cells, 50 % (vol/vol) chilled acid-washed glass beads, 0.5-ram diam) 
by consecutive cycles of 30-s disruption and l-rain  cooling on ice. The com- 
bined lysates were spun at 8,000 rpm in a JA-14 rotor (Beckman Instruments, 
Palo Alto, CA) for 20 rain at 4°C. The supernatants were combined and 
spun in a Ti60 rotor (Beckman Instruments) at 58,000 rpm for 120 rain. 
The resulting supernatants (140 ml, 40-50 mg/ml) were collected, aliquoted 
into microfuge tubes, frozen in liquid nitrogen, and stored at -70°C. 
Isolation of Vacuoles 
Vacuoles were isolated as described in Conradt et ai. (1992), except that 
MgC12 was omitted before flotation. Each vacuole preparation was ana- 
lyzed microscopically and consisted of nonclustered vacuoles, and some 
lipid bodies which in yeast are typically associated with vacuoles. 
In Vitro  Analyses with Isolated Vacuoles 
The protein concentration was determined from the vacuole samples iso- 
lated daily from the strains BJ3505 and DKY6281, as described above. The 
vacuole  preparations  were  adjusted  with  0%  Ficoll  buffer  (10  mM 
Pipes/KOH, pH 6.8, 0.2 M sorbitol) to 0.25 mg protein/ml. Standard reac- 
tions in L5 ml microfuge tubes contained 10/zl of each of the two vacuole 
preparations (0.25 mg/ml), 2.2 #1 of 10x salt buffer (100 mM Pipes/KOH, 
pH 6.8, 1 M sorbitol, 50 mM MgC12, 1 M KC1, 0.5 M KOAc), 3.5 gl of 
a  10x ATP-regenerating system (400 mM creatine phosphate, 20 mg/tni 
creatine pbosphokinase,  10 mM MgATP), Ix  reaction buffer (20 mM 
Pipes/KOH, pH 6.8, 0.3 M sorhltol,  100 mM KC1, 50 mM KOAc, 5 mM 
MgC12), and cytosol (2.2 mg protein/m1). The reaction mixtures were ad- 
justed to a total volume of 35 #1 using lx reaction buffer and incubated 
at 25°C for 120 min (or as indicated). After completion of the reaction, the 
tubes were prewarmed at 30°C for 2 rain and an alkaline phosphatase activ- 
ity assay was performed (Mitchell et al., 1981). 465-#1 assay reaction solu- 
tion (250 mM Tris/C1, pH 8.0, 0.4% Triton X-100, 10 mM MgCI2, 1 mM 
pNPP) was added to each sample. The samples were incubated for 5 min 
at  30°C, the  reactions terminated by the  addition of 500  /~1  1 M gly- 
cine/KOH, pH 11.0, and the A~0 of the samples (0-0.8) were determined 
and corrected for the background (8-10%) due to separate incubations of 
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/~Mol  p-nitrophenol/min//~g  BJ3505-vacuolar  protein  (vacuoles  lacking 
proteinase A but containing proPHOS) or vac2pep4  vacuoles, respectively 
(see Fig. 4). 
When cytosolic preparations from strains other than KgI-1A were used, 
the cytosolic alkaline phosphatase activities (particularly of the PH013 gen¢ 
product; Kaneko et al.,  1989) had to be removed prior to the alkaline phos- 
phatase activity determination. This was accomplished by two sedimenta- 
tion steps after fusion reactions were completed.  Samples were placed on 
ice, and 300/~1 of ico-cold ~washing" buffer (40 mM Tris-Cl, pH 8.0) was 
added.  The samples were shaken on a vortex mixer at highest setting for 
15 s, chilled on ice, and shaken for another 15 s. Membranous material was 
sedimentefi in a mierofuge at 4"C and 14,000 rpm for 15 rain. Pellets were 
resuspended in 300 #1 of ice-cold washing buffer and the vortex steps were 
repeated. After another centrifugation at 14,000 rpm for 15 min, the super- 
natants were discarded and the pellets resuspended in 35/~1  Ix  reaction 
buffer including 2% Triton X-100 (see above). Phosphatase activity was as- 
sayed as above. 
To separate vacuoles from added reagents, a short mierofuge eentrifuga- 
tion was performed (45 to 90 s at 10,000 rpm, 4°C), the supernatant was 
discarded,  and the pellet gently resuspended in 1×  reaction buffer. 
To  reduce  ATP-dependent,  eytosol-independent  fusion  background, 
vacuoles from S. cerevisiae (BJ3505 and DKY6281, mixed 1:1, 0.25 mg pro- 
tein/ral) were preineuhated (where indicated) in a 200/zl volume with 1× 
reaction buffer at 300C for 10 rain, and then collected by a microfuge spin 
at 10,000 rpm for 80 s.  The supernatant was discarded,  the pellet gently 
resuspended in 1× reaction buffer (final concentration 0.23 nag protein/ml) 
and used in fusion reactions. 
For microscopic in vitro assays, 1 ttl CDCFDA (from a 1 mM CDCFDA 
[10% DMSO] stock solution) was added per standard reaction. Small ali- 
quots were removed at the indicated time and analyzed by fluorescence mi- 
croscopy (see Materials and Methods; and Conradt et al.,  1992). 
Immunoblot analysis of proPHO8 maturation was performed as previ- 
ously described for proCPY maturation (Cortradt et al.,  1992). The poly- 
clonal antiserum was used at a 1:5,000 dilution. 2 x  sample buffer contained 
2% SDS, 50 mM Tris-Cl (pH 6.8),  10% glycerol, and 0.01%  bromphenol 
blue. 
Results 
Outline of  the In Vitro Fusion-Quantification Assay 
Vacuoles of S. cerevisiae possess a membrane-bound alka- 
line phosphatase (PH08 gene product) with its catalytic do- 
main oriented into the vacuole lumen (Kaneko et al.,  1987; 
Klionsky and Emr,  1989; Klionsky et al., 1990). Activation 
of PHO8  enzymatic  activity requires  functional  vacuolar 
proteinase A  (PEP4 gene product;  Klionsky et al.,  1990) 
which cleaves the COOH terminus of proPHO8 (Ammeter 
et al., 1986; Klionsky and Emr,  1989). Thus, vacuoles lack- 
ing either PEP4 or proPHO8 have only marginal  alkaline 
phosphatase activity (Jones et al., 1982; Klionsky and Emr, 
1989). 
In the in vitro vacuole-to-vacuole  fusion reactions (Fig. 1), 
vacuoles isolated frompho8 andpep4 strains were incubated 
at 25°C with cytosol, ATP, and an ATP-regenerating  system. 
Under these conditions,  the mixing of vacuolar membranes 
and luminal contents during and after fusion (Conradt et al., 
1992) brings the proPHO8 substrate and PEP4 protease to- 
gether,  which results in the maturation of proPHO8 (appar- 
ent Mr 76,000)  to its enzymatically active  form (apparent 
Mr  72,000;  Klionsky  and  Emr,  1989;  Raymond  et  al., 
1992). After solubilization  of the vacuolar membrane, alka- 
line  phosphatase  activity is  quantified  spectrophotometri- 
cally using pNPP as a chromogenic substrate.  To avoid a 
high background from cytosolic phosphatases, a double de- 
letion mutant in PH08 and PH013 (the  latter encoding a 
cytosolic pNPP-specific phosphatase; Kaneko et al.,  1989) 
Figure L Scheme  of the quantitating vacuole-to-vacuole  fusion as- 
say. For details see text. 
was used as a source of  cytosol. Only trace alkaline phospha- 
tase activities  were detected in such preparations. 
Maturation of  proPH08 Reflects Inter-vacuole Fusion 
The average vacuole diameter,  determined by fluorescence 
microscopy,  increased during incubation  in a standard  reac- 
tion (Fig. 2 A; Conradt et al.,  1992).  This increase in size 
was correlated with increasing  PHO8 maturation (Fig. 2 B) 
and a concurrent increase in alkaline  phosphatase activity 
(Fig. 2 C). These results indicated that vacuole fusion occurs 
in our in vitro reaction. 
ProPHO8 maturation requires physiological  temperature, 
cytosol, ATP, and both types of vacuoles (Fig. 3; also Con- 
radt et al., 1992). The small background of cytosol-indepen- 
dent, ATP-dependent  proPHO8 maturation (Fig.  3, lane 3) 
could be removed by incubating  both vacuole types together 
in lx reaction buffer (10 min, 30°C) with a subsequent reiso- 
lation  of vacuoles by sedimentation  (data not shown).  We 
suggest that this treatment removed fusion-promoting  (cyto- 
solic)  factors which had still been bound to the vacuoles. 
Trypsin-treated  cytosol did not promote fusion in vitro, and 
no fusion could be observed in standard fusion reactions to 
which Triton  X-100 (0.01%) was added, or when vacuoles 
had been pretreated in an ultrasonic waterbath  (Conradt et 
al.,  1992,  data not  shown),  indicating  that  maturation  of 
proPHO8 occurred only in intact vacuoles. 
The VAC2 Gene Product Is Required for In Vitro 
Vacuole-to-Vacuole  Fusion 
Vac24 is a temperature-sensitive  mutant which fails to de- 
liver vacuolar material to the daughter cell in vivo at the non- 
permissive temperature but which seems unaffected  in the 
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Figure 2.  Kinetics  of in  vi- 
tro vacuole-to-vacuole  fusion. 
All data stem from  the  same 
experiment.  Isolated vacuoles 
were incubated in a large scale 
fusion assay which consisted 
of a  multiple  volume of the 
standard assay. Samples in 12 
ml  Falcon  tubes  containing 
the  reaction mixture without 
added  ATP were  transferred 
from  ice  to  25°C  and  pre- 
warmed for 90 s. ATP and its 
regenerating  system  were 
added,  the  tube  was  gently 
shaken,  and immediately the 
"0-min  samples"  were  re- 
moved.  At  the  indicated 
timepoints,  aliquots  were re- 
moved and microphotographed 
(A) or placed  on ice  (B and 
C). (A) Vacuoles were labeled 
with the specifically  vacuole- 
staining  reagent,  CDCFDA 
(see Materials  and Methods). 
(B) Anti-PHO8 Western blot. 
After completion of the reac- 
tion  (180 min), one  volume 
(35 td) 2x  sample buffer was 
added to the samples  and the 
samples were heated for 2 min 
incubation  at 25"0 (min)  at  95°C.  One  third  of each 
sample  (for  each  timepoint) 
was separated  in a 10% acrylamide/SDS gel, the sample proteins were electrotransferred  onto PVDF membranes (Bio-Rad Laboratories) 
and probed with an anti-PHO8 serum. (C) After completion of the reaction, duplicate  samples  (35-/~1 each)  were analyzed for alkaline 
phosphatase activities.  Bar,  2.9 tzm. 
inheritance  of other organelles (Shaw and Wickner,  1991). 
Vac2-1-derived vacuoles fragment in vitro and fail to fuse 
during even prolonged incubation in the presence of  ATP and 
cytosol from wild-type parent strains (Conradt et al.,  1992). 
In an alkaline phosphatase maturation assay with vacuoles 
isolated from vac2-1 pep4 and vac2-1 pho8, respectively, to- 
gether with cytosol from a wild-type strain, virtually no fu- 
sion could be detected. Vacuoles isolated from the respective 
parent  strains,  however,  fuse normally under these  condi- 
tions (Fig. 4). When vac2-1 pho8- or vac2-1 pep4-derived 
Figure  3.  Requirements  for 
alkaline  phosphatase matura- 
tion  in vitro.  Standard  reac- 
tions  with  all  components 
(lane  1),  or lacking  compo- 
nents  (lanes  2-6),  or placed 
on ice (lane 7), or with added 
inhibitor (lanes 8 and 9) were 
incubated  in  triplicate.  For 
each  sample  type,  alkaline 
phosphatase  activities  were 
determined  from  duplicates 
(the mean of which is shown 
here). The remaining samples 
were used  for Western  blot- 
analysis  as in B. The alkaline 
phosphatase  activities  shown 
in  this  figure  have  not  been 
corrected  for  the  enzymatic 
activity background produced 
by  the  endogenous  alkaline 
phosphatase activities of  cyto- 
sol and vacuoles (0.07 U). 
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Figure 4. Vacuoles isolated from vac2-1 cells do not fuse. Vacuoles 
were  isolated from  vac2-I  mutant  cells  and parent  strain cells 
(VAC2) grown at 23°C. vac2-1/pho8  and VAC2/phoS-derived  vacu- 
oles  were  incubated  with  vac2-1/pep4 and  VAC2/pep4-derived 
vacuoles, respectively. The final volume per sample  was 60/zl, 
vacuoles were present  at a  final concentration of 0.09  mg  pro- 
tein/ml, cytosol from S. cerevisiae  ABYS1 was added to a final con- 
centration of 2.0 nag proteirdml, and an ATP-regenerating system 
was used (same composition as in the standard assay). After com- 
pletion of the reaction (120 rain, 23°C),  ABYSl-cytosol was re- 
moved from the vacuoles by a spin in a microfuge (15 rain, 14,000 
rpm,  4°C).  The resulting vacuole membrane pellets were resus- 
pended in 35/zl of a lx  reaction buffer/l%  (wt/vol) Triton X-100 
solution (per sample)  and the alkaline phosphatase activities were 
determined as in the standard reaction. The alkaline phosphatase 
activities shown here refer to a buffer blank (the background of al- 
kaline phosphatase activity intrinsic to wild-type vacuoles and 
cytosol is 0.12 U). 
vacuoles  were  mixed  with vacuoles from  VAC2 pep4  or 
VAC2 phoS, respectively, intermediate fusion activities were 
measured (data not shown). This defect in fusion of vac2- 
/-derived vacuoles was  even pronounced at a  permissive 
temperature which allows the formation of segregation struc- 
tures in semi-intact cells (Conradt et al., 1992). Since wild- 
type cytosol was used in these experiments, the vac2-1 defect 
must be associated wih the vacuole itself. We conclude that 
our in vitro fusion reactions reflect physiological vacuole-to- 
vacuole fusion. 
Inhibitors of In Vitro Vacuole Fusion Reactions 
Neomycin is an aminoglycoside  antibiotic which is known to 
bind strongly to phosphatidylinositol-polyphosphates, par- 
ticularly to the diphosphate form (Lodhi et al., 1979; Prentki 
et al., 1986) preventing their further metabolism (Marche et 
al., 1983; Carney et al., 1985; Gabev et al., 1985). Neomy- 
cin blocks inter-vacuole fusion in our assay at a relatively low 
concentration (0.2 mM; Fig. 5 A). Both CCCP, which un- 
couples  the  proton  gradient across  vacuolar  membranes 
(Anraku et al.,  1989)  and batilomycin A~, which inhibits 
the generation of such a proton gradient (Bowman et al., 
1989; Klionsky et al., 1990) also inhibited vacuole fusion in 
vitro (Fig. 5, B and C). Microscopy confirmed that these in- 
hibitory effects correlated with a significant decrease in fu- 
sion frequency (Fig. 6, D and E). Vacuoles in a standard fu- 
sion reaction increased in size in an ATP-dependent manner 
(Fig. 6 A) relative to a control reaction with Pipes/KOH as 
the  sole  salt  (Fig.  6  B),  while  addition  of  neomycin, 
batilomycin A~,  or CCCP blocked vacuole fusion but al- 
lowed vacuole aggregation (Fig.  6,  C-E).  None of these 
compounds inhibited catalysis by mature alkaline phospha- 
tase, as determined by measuring proPHOS-maturation in 
the presence of these compounds by immunoblot analysis 
and comparison with the data obtained in the alklaine phos- 
phatase activity measurements. 
In Vitro Vacuole-to-Vacuole Fusion Is Inhibited by 
Non-hydrolyzable  Guanosine Nucleotides 
GTP3,S reduced proPHO8 maturation by 50% at 0.4 mM, 
and by  90%  (maximal inhibition)  at  1.5  mM  (Table  I). 
Microscopically, vacuoles were observed to cluster in the 
presence of GTPTS, but fusion was largely inhibited (Fig. 6 
F).  Nonhydrolyzable GTP/~S and GDP/3S also clearly in- 
hibited the reaction (Table  I).  Neither hydrolyzable GTP, 
GDP,  nor  guanosine  3';5'-cyclic monophosphate (cGMP) 
affected the reaction at the concentrations tested (Table I). 
G-protein-activating Mastoparan Inhibits In Vitro 
Vacuole Fusion and Is Antagonized by BAC 
Mastoparan, a 14-amino acyl wasp venom peptide (Hirai et 
al.,  1979),  activates  some  heterotrimeric  G-proteins  by 
stimulating a  GTP-for-GDP exchange on their o~-subunits 
(Higashijima et al.,  1988, 1990;  Weingarten et al.,  1990). 
In the presence of mastoparan the in vitro fusion reaction 
was inhibited (see Fig.  8 A).  The mastoparan derivatives 
masX and mas7  (Higashijima et al.,  1990)  and synthetic 
mastoparan-derived peptide 8  (Oppi  et al.,  1992),  previ- 
ously shown to also be potent G-protein activators, inhibited 
inter-vacuole fusion with approximately the same efficiency 
as mastoparan. The synthetic mastoparan-derivative masl7 
(Higashijima et al., 1990) and the mastoparan-derived pep- 
tides 2 and 7 (Oppi et al., 1992; data not shown for peptide 
7),  all of which do not stimulate G-proteins in vitro,  in- 
hibited fusion slightly and then only at high concentrations 
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Figure 5.  Effects of some re- 
agents on the in vitro vacuole- 
to-vacuole fusion  frequency. 
Neomycin  (A), bafilomycin 
Al (B), and CCCP (C) were 
added to standard reactions at 
the indicated final concentra- 
tions. Fusion was performed 
and analyzed as indicated for 
the standard assay in the Ma- 
terials and Methods section. 
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of  standard  fusion  samples 
containing various inhibitors 
of the fusion reactions. Vacu- 
oles  were  labeled  with 
CDCFDA and standard vacu- 
ole fusion reactions were in- 
cubated  for  120  rain  as  de- 
scribed in the  Materials and 
Methods  section.  (A)  Stan- 
dard fusion reaction,  (B) fu- 
sion  reaction  lacking  KCI, 
KOAc, and MgCI2, but con- 
taining all other components, 
(C) neomycin (0.6 raM), (/9) 
bafilomycin At (20/zM), (E) 
CCCP (20/zM), (F) GTP3/S 
(1.0 raM),  (G) mastoparan 7 
(20  /~M), (H)  mastoparan 
7  [Q4;Qll]  (20  /~M). Bar, 
2.9 t~m. 
(Fig. 7 A). Mas7[Q4;Qll] is a mas7 derivative in which two 
lysyl residues have been replaced by glutamyl residues. This 
derivative forms an a-helix upon binding to membranes and 
is  as potent as  mas7 in  its membrane-blnding properties; 
however, it does not stimulate G-proteins (Higashijima, T., 
personal  communication).  Mas7[Q4;Qll]  did  not  inhibit 
inter-vacuole fusion at concentrations up to 50 #M, but did 
inhibit at a very high concentration (100/~M; Fig. 7 A). In 
summary, these data indicate that the inhibition of fusion 
by mas7  (at  20  #M)  is  probably  not  due  to  membrane- 
destabilizing  effects.  To determine  whether the  effects of 
mastoparans are still due to their interactions with vacuole 
Table I.  Effects of Various Guanosine Nucleotides on the 
In  Vitro Fusion Reactions 
Reagent  Final concentration  Percent  inhibition (SD) 
mM 
GTP.yS  0.2  33 (5.1) 
0.4  53 (3.6) 
0.8  69 (2.1) 
1.5  89 (3.6) 
GDPBS  0.5  27 (10) 
1.0  39 (18) 
2.0  61 (15) 
GTPBS (Rp-isomer)  0.5  23 (5.9) 
1.0  42 (2.6) 
2.0  61 (6.7) 
GTP  1.0  10 (13) 
2.0  14 (13) 
GDP  1.0  -3 (10) 
2.0  6 (8.2) 
cGMP  2.0  9 (4.4) 
The vacuoles used in these experiments had been subjected to a preincubation 
step (see Materials and Methods) to reduce ATP-dependent,  cytosol-indepen- 
dent fusion. Each reagent was tested in duplicate in all experiments.  Lithium, 
which is present as a counterion in most OTP-derivative preparations,  did not 
influence the fusion reactions. Data from three to five independent experiments 
were used to calculate each standard deviation. 
membranes, vacuoles were briefly preincubated with various 
concentrations of mastoparan and reisolated by centrifuga- 
tion. These vacuoles were inhibited for fusion (Fig. 7 B). 
Preincubation of cytosol with up to 100 ~M mastoparan (10 
min, 25°C) did not significantly influence its fusiogenic ac- 
tivity (Fig. 7 C), supporting the suggestion that mastoparans 
act on the vacuole membrane rather than  on a  cytosolic 
factor. 
Mastoparan-mediated inhibition of alkaline phosphatase 
activity was  not due to a  direct inhibition in the alkaline 
phosphatase catalytic activity (Fig. 3, lanes 8 and 9; this fea- 
ture has also been confirmed for all other inhibitors used in 
this study; data not shown). Furthermore, in a standard reac- 
tion,  fusion-inhibiting  mastoparans  caused  vacuole  frag- 
mentation (Fig. 6 G), whereas Mas7[Q4;Qll] did not (Fig. 
6 H). This "fragmentation" might be interpreted as a consti- 
tutive formation of segregation structures, forming vesicles 
which do not have the ability to fuse. In  summary, those 
mastoparan derivatives which activate G-proteins inhibited 
fusion, while those homologs which do not influence G-pro- 
tein activity did not influence vacuole fusion. 
Benzalkonium chloride (BAC) is a hydrophobic quarter- 
nary amine which stimulates GTPase activity and nucleotide 
exchange of purified Gi and which antagonizes the stimula- 
tory effect of mastoparan on the GTPase activity of purified 
Go (Higashijima et al.,  1990; Mousli et al.,  1990; Fischer 
et al., 1993). By this action, it reverses the effects of masto- 
paran on exocytosis in chromaflin cells (Vitale et al.,  1993) 
and the effects of other cationic compounds on histamine re- 
lease from mast cells (Read and Kiefer, 1979; Mousli et al., 
1990). BAC itself inhibited inter-vacuolar fusion (Fig. 8) with 
maximal effects at  10 #g/ml.  Strikingly, BAC antagonized 
the  inhibition  of  vacuole-to-vacuole  fusion  caused  by 
mastoparan (at a concentration of 20 #M), again with a max- 
imal effect seen at 10 #g/ml. The same BAC concentration 
is needed to reverse mastoparan effect on purified Go pro- 
teins (Higashijima et al.,  1990). Triton X-100 was used as 
a detergent control for BAC (Read and Kiefer, 1979). It did 
not inhibit vacuole fusion, even at the highest concentration 
tested  (30  /zg/ml),  and  did  not  influence  the  effects of 
mastoparan on fusion (Fig.  8). 
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Figure 7. Effects of various mastoparan derivatives on the in vitro 
vacuole-to-vacuole fusion efficiency. (A) Effects on fusion by addi- 
tion to the standard reaction of mastoparan-peptide 2 (MAS-PEP2, 
closed  small circules),  mastoparan 17 (MAS17, D), mastoparan 
(MAS,  open  triangles),  mastoparan  X  (MAS  X,  ,,),  and 
mastoparan-peptide  8 (MAS-PEPS, o), mastoparan 7 (MAS7, e) 
and  the  mastoparan 7  derivative,  MAS7[Q7;Qll]  (A).  For  the 
amino  acid  sequences  of the  mastoparan derivatives,  see  the 
Materials  and  Methods.  (B)  Preincubations  of  vacuoles  with 
mastoparan before the fusion assay. Vacuoles from strains BJ3505 
and DKY6281 were diluted to 0.25 mg/ml protein with vacuole iso- 
lation buffer (250 mM sorbitol, 10 mM Pipes/KOH, pH 6.8). These 
preparations  were mixed and  1/10 final volume of 10x  reaction 
buffer (see Materials and Methods),  and various mastoparan con- 
centrations  in Ix reaction buffer were added.  The mixtures were 
transferred to a 25°C waterbath for 5 min, placed again on ice, and 
then centrifuged (microfuge, 80 s, 10,000 rpm, 4°C). Supernatants 
were discarded and the pellets gently resuspended in reaction buffer 
and used in standard fusion reactions (e). All vacuolar protein was 
recovered in the pellet under these conditions and the resuspended 
vacuoles were not fragmented (as judged by microscopy). In paral- 
lel, vacuoles were pretreated as above, but with reaction buffer only. 
To the latter samples only, mastoparan was added to the indicated 
final concentrations  in standard fusion reactions (n). (C) Cytosol 
was preincubated with various concentrations  of mastoparan (0 to 
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Figure 8. Effects of mastoparan and BAC on inter-vacuole fusion. 
Standard fusion assays were incubated with the indicated concen- 
trations  ~g/ml) of BAC or Triton X-100 alone (o and m, respec- 
tively),  or with the indicated concentration  of BAC plus 20 #M 
mastoparan  (A), or Triton X-100 plus 20/~M mastoparan (n). 
Discussion 
The choice of proPHO8 as the substrate protein for matura- 
tion by PEP4 after vacuole fusion has several important ad- 
vantages over, e.g., procarboxypeptidase Y: (a) proPHO8 is 
a membrane protein (Klionsky and Emr, 1989) and thus can 
be isolated with vacuole membranes, even under conditions 
which lead to vacuole lysis. Vacuole membrane isolation af- 
ter in vitro fusion allows cytosol peparations from various 
yeast mutants (e.g., vac, vps) to be used in this assay system 
(i.e., from cells with high levels of cytosolic alkaline phos- 
phatase  activities).  (b)  PHO8  is  the  only known  vacuole 
membrane protein whose enzymatic activity is dependent on 
cleavage by PEP4 (Klionsky et al.,  1990).  (c) Cytosol can 
be prepared from a mutant yeast strain with very low alkaline 
phosphatase activity, making cytosol removal unnecessary 
after standard fusion reactions (see Materials and Methods 
section).  (d)  ProPHO8 and other vacuole membrane pro- 
teins are delivered to the vacuole in vivo by transport path- 
ways which are different from those for the vacuole luminal 
proteins carboxypeptidase Y (CPY), PEP4, or proteinase B 
(Klionsky and Emr, 1989). Thus, proPHO8-transport is in- 
sensitive to numerous vacuole protein sorting (vps) muta- 
tions. In contrast, transport of CPY or proteinase B is VPS 
dependent (Klionsky and Emr, 1989; Raymond etal., 1992). 
As most of the vacuole biogenesis mutants mislocalize CPY 
to  the  cell  surface  (Klionsky et al.,  1990;  Weisman and 
100 ttM, in Ix reaction buffer) at 25°C for 10 min. Cytosol was 
diluted 26.5-fold into standard  reactions  ([]). In parallel,  cytosol 
was preincubated with reaction buffer only and added to standard 
reactions which received the same amount of mastoparan that was 
introduced by mastoparan-preincubated  cytosol into the other sam- 
ples (the final concentrations  in fusion reactions were between 0 
and 3.8 ~M; m). All data are averages of two parallel fusion reac- 
tions and the "0" data again represent two parallel cytosol preincu- 
bations with reaction buffer. Fusion was performed for 120 rain at 
25°C and alkaline phosphatase  activities were determined  as de- 
scribed in Materials and Methods. 
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localized to the vacuole and thus available for the in vitro fu- 
sion assay for each newly identified vacuole segregation mu- 
tant: (e) transport of proPHO8 from the Golgi apparatus to 
the vacuole and proPHO8 maturation are not strictly depen- 
dent upon vacuole acidification (Klionsky and Emr,  1989; 
Klionsky et ai.,  1990). This allows separate studies of the 
roles of acidification and of an electrochemical potential in 
vacuole fusion in vitro (Klionsky et al.,  1990). 
By using a vacuole inheritance mutant (vac2-1), we have 
shown that the in vitro  reactions presented  here reflect in 
vivo inheritance processes. Furthermore,  another nonailelic 
vacuole  inheritance  mutant  (vac5)  is  also  defective  in 
vacuole-to-vacuole fusion in vitro (Nicolson,  T., L. Weis- 
man, G. Payne, and W. Wickner, unpublished data). 
The proPHO8-maturation  assay has been used to define 
some effects  of  biochemical reagents on inter-vacuole fusion. 
Reagents which block the H÷-translocating ATPase or un- 
couple the proton gradient across the vacuole membrane in- 
hibit inter-vacuole fusion in vitro. This was not merely due 
to a diminished maturation of proPHO8 by PEP4 in a more 
alkaline environment.  Our microscopic observations show 
that CCCP and bafilomycin A~ allow vacuole aggregation 
but prevent fusion. Furthermore,  recent studies showed that 
normal  precursor  protein  maturation  can occur  in  yeast 
vacuoles with an elevated pH (Yamashiro et al., 1990). Thus, 
a loss in acidification and/or a drop in the electrochemical 
potential across the membrane  inhibited fusion frequency. 
This may be due to a reduced binding of cytosolic factors to 
vacuole membranes, similar to the decreased binding of  ADP- 
ribosylation factor to bafilomycin-treated microsomal mem- 
branes (Zeuzem et ai., 1992). Clague et al. (1994) showed 
that the formation of a vesicular intermediate between early 
and late endosomes (endosomal carder vesicles) is impaired 
by inactivation of the endosomal  ATPase via bafilomycin 
At. Thus, further studies are needed to investigate whether 
the formation of segregation structures is impaired in bafilo- 
mycin-treated samples. Inhibition of  fusion by neomycin may 
reflect the involvement of phosphatidyl  inositol-polyphos- 
phatase.  A role for the inositol-signaling pathway has re- 
cently been  shown in vitro  during  nuclear  vesicle fusion 
(Sullivan et al., 1993), and similar processes might play a 
role in vacuole fusion processes (see also Burgoyne, 1994). 
Inhibition of vesicular transport processes by GTP3,S is a 
hallmark of GTP-binding and hydrolyzing (G-) proteins in 
intraceUular trafficking events (Gruenberg and Clague, 1992; 
Pfeffer, 1992; Pryer et al., 1992; Rothman and Orci,  1992). 
We have performed GTP-binding blots Water et al., 1992) 
which have shown that there are at least five different "small" 
GTP-binding proteins present in our vacuole isolates (data 
not shown). We observed a considerable inibition of inter- 
vacuole fusion by GTP3,S (70% at 0.8 mM, and 90% at 1.5 
mM).  These  inhibitory concentrations  are clearly  higher 
than those necessary  to block vesicular transport  in some 
other in vitro systems (Mayorga et al.,  1989b; Rexach and 
Schekman, 1991; Leyte  et al., 1992; Carter et al., 1993), but 
are approximately the same concentrations necessary for the 
inhibition of in vitro vesicle fusion during nuclear envelope 
assembly in Xenopus eggs (Boman et al., 1992) and retro- 
grade transport from the Golgi region to the ER in human 
hepatoma cells (Tan et ai., 1992). Interestingly, Taylor et al. 
(1992) found that GTP3,S did not inhibit their in vitro intra- 
Golgi transport  reactions although a role for small G-pro- 
teins had clearly been established. These authors suggested 
that this was due to the fact that GTP~S might not have been 
bound to the respective G-protein(s).  Thus,  in our fusion 
system, replacement of  bound GDP by GTP3~S might, in the 
absence of a  GTP-exchange factor (Boguski and McCor- 
mick,  1993), be necessary  to inhibit the fusion reactions 
(i.e., activation of G-proteins, not GTP hydrolysis by acti- 
vated G-proteins, would be necessary for fusion inhibition). 
In this case, high GTP3,S concentrations may favor a spon- 
taneous  exchange  reaction  over  rebinding  of previously 
bound  GDP. Guanine  nucleotide-dissociation  inhibitors 
(Boguski and McCormick,  1993) may interfere as well. 
The inhibition of vacuole fusion by GTPBS (Ro-isomer) 
is remarkable.  GTP/SS has been used to probe the stereo- 
specificity of GTP-binding sites in G-proteins. Most G-pro- 
teins have a much lower affinity for GTP/~S than for GTP'rS 
or GTP (e.g., 1/10,000 the affinity in transducin, Yamanaka 
et al., 1985; 1/15 the affinity in c-Ha-ms, Tucker et al., 1986; 
Jones et al., 1990; Paris and Eckstein, 1992). In our system, 
only approximately  twice  as  much GTP/~S as  GTP~S  is 
needed for the same inhibition.  Thus,  GTPBS might be a 
useful probe to identify the G-protein(s) involved in vacuole- 
to-vacuole fusion. The lack of GDP-mediated inhibition of 
fusion, together with a clear GDP/~S-dependent inhibition, 
could be explained by the presence of cytosolic diphospho- 
nucleotide  kinase which  catalyzes  the transfer  of 3,-phos- 
phate from ATP (which is constantly present in our reactions 
at a concentration of 1 mM) to GDP, thus creating G-protein- 
activating GTP. The same phenomenon has been described 
for G-protein-dependent  vesicle formation from yeast ER 
(Barlowe et al., 1993). GDPBS, in contrast to GDP, is not 
phosphorylated  and may compete with GDP and, particu- 
larly, GTP for the binding to G-proteins. At 2 raM, GDP/3S 
may lock most G-proteins in their inactive state, thus, inhib- 
iting fusion reactions. 
Inhibition of fusion by GTP derivatives alone is, however, 
not sufficient proof for the involvement of G-proteins in this 
reaction. Other reagents which are relatively specific for cer- 
tain (mammalian) G-protein subclasses could not be used in 
our  studies:  aluminum  fluoride  strongly  activates  mam- 
malian heterotrimeric  G-proteins by mimicking the ortho- 
phosphate on bound GDP (Bigay et al., 1987). However, in 
our reaction fluoride itself was inhibitory (data not shown). 
Pertussis toxin, which inhibits mammalian heterotrimeric 
G-proteins (Kopf and Woolkalis, 1991), does not function in 
yeast;  the three  so far published  fungai G-protein  a-sub- 
unit sequences (Dietzel and Kurjan,  1987; Nakafuku et al., 
1987,  1988; Obara  et al.,  1991) lack the cysteine residue 
which, in some mammalian ~-subunits, is the target for ADP 
ribosylation (McDonald,  1992). 
The use of mastoparan  and its derivatives, however, has 
been fruitful. Though mastoparan has also been reported to 
activate  purified  phospholipase  C  (Wallace and  Carter, 
1989), nucleotidases  (Bomsel and Mostov, 1992), and to 
bind strongly to calmodulin (Malenik and Anderson, 1983), 
many trafficking events are selectively inhibited by the G-pro- 
tein-stimulating  activity of mastoparans  (as shown by the 
prevention  of  mastoparan  effects by  adding  antibodies 
specifically directed  against certain  c~-subunit COOH  ter- 
mini; Carter et al., 1993; Pimplikar and Simons, 1993; Vi- 
tale et al., 1993). Our results show that mastoparan strongly 
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tical to those needed either for fusion inhibition in these 
other in vitro systems or for the activation of mammalian 
G-proteins  in  vitro  (where  the  concentration  for  half- 
maximal inhibition was 10/~M; Higashijima et al.,  1990). 
A  mastoparan derivative, mas7[Q4;Qll],  was only inhibi- 
tory at a very high concentration (100 #M), whereas mas7 
[K4;Kll] was inhibitory in the low micromolar range. The 
[Q4;Qll]  derivative binds as  strongly to lipid bilayers as 
the [K4;Kll] variant (as determined by circular dichroism 
spectra),  although it clearly does  not activate G-proteins 
(Higashijima, T., personal communication; the lysine resi- 
dues in mastoparan have previously been shown to be critical 
for the activation of G-proteins; Higashijima et al.,  1990; 
Sukumar and Higashijima, 1992).  Furthermore, there was 
only a weak influence of 20 tzM Mas7[Q4;Qll] on the in- 
crease in size of  vacuoles in a microscopy fusion assay. How- 
ever, 20 #M Mas7 led to vacuole fragmentation. These data 
strongly suggest that inhibition of fusion by 20 ttM mas7 was 
not due to membrane perturbation but due to an interaction 
of mas7 with a membrane component. This agrees with the 
observation that preincubation of cytosol with up to 100/zM 
mastoparan did  not inhibit its  fusion-promoting activity. 
Thus, small rho-like proteins (Koch et al.,  1991) or other 
cytosolic factors are not directly involved in the inhibition 
of fusion by mastoparan. Mas7[Q4;Q11]  did not relieve the 
inhibition caused by mas7 effects when both compounds were 
added together (data not shown), suggesting that mas7[Q4; 
Q11] does not bind to the receptor-binding site of the putative 
target G-protein. Mas7[Q4;Qll] is the best available control 
for  excluding  membrane-disturbing  side  effects:  Mas17, 
which is commonly used for this purpose, does not assume 
an a-helical structure in the presence of membrane and thus 
binds to them only weakly (Higashijima et al., 1990).  Two 
other Mas derivatives, the Mas-derived peptides 2  and 7 
(Oppi et al.,  1992),  which do not stimulate G-proteins in 
vitro, were also inactive in the fusion assay. 
BAC antagonized the mastoparan-induced inhibition of fu- 
sion. Both mastoparan and BAC have only negligible deter- 
gent effects at the concentrations which show clear effects in 
our assay of  vacuole fusion (Katsu et al., 1990; Vaara,  1992). 
When applied together they show less inhibition of fusion 
than mastoparan alone, suggesting that there are specific tar- 
gets for these compounds in this system. The detergent Tri- 
ton X-100 did not influence fusion frequency when added at 
the same concentrations at which BAC inhibited. Recently, 
it has been shown that BAC antagonizes the stimulation of 
purified G~ protein by mastoparan,  whereas  mastoparan- 
induced stimulation of purified Go protein  remains unaf- 
fected (Higashijima et al.,  1990).  On the other hand, BAC 
alone stimulates the activity of purified Go but not of G~ 
(Higashijima et al., 1990),  and inhibits Go-regulated exocy- 
tosis in chromaffin cells (Vitale et al., 1983). The BAC con- 
centrations necessary to observe similar effects in these sys- 
tems were again about the same as those needed in our in 
vitro system. 
Considering, (a) the inhibition of fusion by mastoparan 
derivatives which are active towards isolated G-proteins (but 
not by those that are inactive towards G-proteins); (b) the fact 
that mastoparan acts on the vacuoles rather than the cytosol; 
(c) fusion inhibition by BAC; (d) the antagonizing effect of 
BAC on mastoparan-induced fusion-inhibition, and (e) the 
inhibition of fusion by GTP'yS, GTP/3S, and GDP/3S (but not 
by GTP, GDP, or cGMP), we suggest the following hypothe- 
sis. There may be vacuolar membrane proteins which react 
in the same manner as Gi and Go (no  such classification 
currently exists for yeast G-proteins).  These proteins may 
normally stimulate or inhibit fusion but, once constitutively 
activated by mastoparan or nonhydrolyzable GTP analogues, 
they inhibit fusion. In fact, inhibition of intracellular traf- 
ticking events by mastoparans has been shown to be either 
due to Gi (Stow et al., 1991; Pimplikar and Simons, 1993; 
Wilson et al., 1993),  or Go (Vitale et al., 1993).  The inter- 
action of two different types of  heterotrimeric G-proteins has 
already been shown for other trafficking systems (Colombo 
et al.,  1992;  Leyte et al.,  1992;  Pimplikar and Simons, 
1993). It is also possible that a single vacuolar protein which 
combines  features  of both  Go  and  G~  proteins  regulates 
vacuole fusion.  Heretofore, neither mastoparan nor BAC 
have been used in yeast in vitro models, nor have heterotri- 
meric G-proteins been assigned a role in vesicular transport 
in yeast. Of course, monomeric G-proteins may also be in- 
volved in inter-vacuole fusion. Fractionation of the proteins 
in our in vitro reaction will be required for the molecular 
identification of such factors. 
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